Research Progress on Correlation between Stroke and Alcohol Use Disorder

doi:10.3969/j.issn.1673-5765.2024.05.012

Abstract

Abstract: Alcohol use disorder, as the fifth largest risk factor worldwide, is an important component of stroke prevention. In recent years, a large number of epidemiological and clinical studies have shown that there is a correlation between alcohol and stroke. Alcohol can affect cardiovascular and cerebrovascular health through various ways, resulting in stroke and even death. At the same time, some studies have shown that there may be different associations between alcohol and stroke, light drinking may be a cardiovascular and cerebrovascular protective factor, and moderate and heavy drinking may induce and aggravate stroke. This paper analyzed the current prevalence of stroke complicated with alcohol use disorder, reviewed the possible pathogenesis of alcohol use disorder affecting the incidence of stroke, and summarized alcohol intake monitoring biomarkers and treatments related to alcohol use disorder, in order to further explore the correlation between stroke and alcohol use disorder and provide ideas for clinical diagnosis and treatment.

Key words: Stroke; Alcohol use disorder; Correlation; Review

摘要： 酒精使用所致障碍作为全球第五大风险因素，是卒中预防的重要内容。近年来大量流行病学和临床研究显示，酒精使用与卒中之间存在相关性，酒精可通过多种途径影响心脑血管健康，从而引发卒中甚至死亡。同时也有研究显示，酒精使用与卒中之间或许存在不同的关联性，轻度饮酒可能是心脑血管的保护因素，中重度饮酒可能会诱发、加重卒中。本文分析了卒中合并酒精使用所致障碍的流行现状，对酒精使用所致障碍影响卒中发病的可能机制进行综述，同时总结了酒精摄入监测生物标志物和酒精使用所致障碍的治疗方式，以期进一步探讨卒中与酒精使用所致障碍之间的相关性，为临床诊疗提供思路。

关键词: 卒中; 酒精使用所致障碍; 相关性; 综述

CLC Number:

LIAO Jia, QUAN Fengying. Research Progress on Correlation between Stroke and Alcohol Use Disorder[J]. Chinese Journal of Stroke, 2024, 19(5): 563-572.

廖佳, 全凤英. 卒中与酒精使用所致障碍相关性的研究进展[J]. 中国卒中杂志, 2024, 19(5): 563-572.

References

[1] JUNG M H，SHIN E S，IHM S H，et al. The effect of alcohol dose on the development of hypertension in Asian and western men：systematic review and meta-analysis[J]. Korean J of Intern Med，2020，35（4）：906-916.
[2] SACKS J J，GONZALES K R，BOUCHERY E E，et al. 2010 national and state costs of excessive alcohol consumption[J/OL]. Am J Prev Med，2015，49（5）：e73-e79[2023-08-10]. https://doi.org/10.1016/j.amepre.2015.05.031.
[3] ROERECKE M. Alcohol’s impact on the cardiovascular system[J/OL]. Nutrients，2021，13（10）：3419[2023-08-10]. https://doi.org/10.3390/nu13103419.
[4] CARVALHO A F，HEILIG M，PEREZ A，et al. Alcohol use disorders[J]. Lancet，2019，394（10200）：781-792.
[5] GBD 2016 Alcohol and Drug Use Collaborators. The global burden of disease attributable to alcohol and drug use in 195 countries and territories，1990—2016：a systematic analysis for the global burden of disease study 2016[J]. Lancet Psychiatry，2018，5（12）：987-1012.
[6] ZHANG T T，LIU Z R，LI G H，et al. Correlates of transitions from alcohol use to disorder diagnosed by DSM-5 in China[J/OL]. BMC Psychiatry，2021，21（1）：427[2023-08-10]. https://doi.org/10.1186/s12888-021-03413-w.
[7] WITKIEWITZ K，LITTEN R Z，LEGGIO L. Advances in the science and treatment of alcohol use disorder[J/OL]. Sci Adv，2019，5（9）：eaax4043[2023-08-10]. https://doi.org/10.1126/sciadv.aax4043.
[8] COHEN S M，ALEXANDER R S，HOLT S R. The spectrum of alcohol use：epidemiology，diagnosis，and treatment[J]. Med Clin North Am，2022，106（1）：43-60.
[9] DONROE J H，EDELMAN E J. Alcohol use[J]. Ann Intern Med，2022，175（10）：145-160.
[10] WU L，ZHANG Y M，REN J. Epigenetic modification in alcohol use disorder and alcoholic cardiomyopathy：from pathophysiology to therapeutic opportunities[J/OL]. Metabolism，2021，125：154909[2023-08-11]. https://doi.org/10.1016/j.metabol.2021.154909.
[11] O’KEEFE E L，DINICOLANTONIO J J，O’KEEFE J H，et al. Alcohol and CV health：Jekyll and Hyde J-curves[J]. Prog Cardiovasc Dis，2018，61（1）：68-75.
[12] O’DONNELL M J，CHIN S L，RANGARAJAN S，et al. Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries（INTERSTROKE）：a case-control study[J]. Lancet，2016，388（10046）：761-775.
[13] GBD 2019 Stroke Collaborators. Global，regional，and national burden of stroke and its risk factors，1990—2019：a systematic analysis for the global burden of disease study 2019[J]. Lancet Neurol，2021，20（10）：795-820.
[14] WANG W Z，JIANG B，SUN H X，et al. Prevalence，incidence，and mortality of stroke in China：results from a nationwide population-based survey of 480 687 adults[J]. Circulation，2017，135（8）：759-771.
[15] WAKEMAN S E，HERMAN G，WILENS T E，et al. The prevalence of unhealthy alcohol and drug use among inpatients in a general hospital[J]. Subst Abus，2020，41（3）：331-339.
[16] SAITZ R，FREEDNER N，PALFAI T P，et al. The severity of unhealthy alcohol use in hospitalized medical patients：the spectrum is narrow[J]. J Gen Intern Med，2006，21（4）：381-385.
[17] ALEXIOU A，KING T. Alcohol withdrawal[J/OL]. BMJ，2023，381：951[2023-08-10]. https://doi.org/10.1136/bmj.p951.
[18] KÄHKÖNEN S，ZVARTAU E，LIPSANEN J，et al. Effects of alcohol withdrawal on cardiovascular system[J]. Prog Neuropsychopharmacol Biol Psychiatry，2011，35（2）：550-553.
[19] JOCHUM T，REINHARD M，BOETTGER M K，et al. Impaired cerebral autoregulation during acute alcohol withdrawal[J]. Drug Alcohol Depend，2010，110（3）：240-246.
[20] AKANO E O，OTITE F O，CHATURVEDI S. Alcohol withdrawal is associated with poorer outcome in acute ischemic stroke[J/OL]. Neurology，2019，93（21）：e1944-e1954[2023-08-10]. https://doi.org/10.1212/WNL.0000000000008518.
[21] WANG J N，SUN W，WELLS G A，et al. Differences in prevalence of hypertension and associated risk factors in urban and rural residents of the northeastern region of the People’s Republic of China：a cross-sectional study[J/OL]. PLoS One，2018，13（4）：e195340[2023-08-10]. https://doi.org/10.1371/journal.pone.0195340.
[22] HUANG Y Q，WANG Y，WANG H，et al. Prevalence of mental disorders in China：a cross-sectional epidemiological study[J]. Lancet Psychiatry，2019，6（3）：211-224.
[23] ROERECKE M，TOBE S W，KACZOROWSKI J，et al. Sex-specific associations between alcohol consumption and incidence of hypertension：a systematic review and meta-analysis of cohort studies[J/OL]. J Am Heart Assoc，2018，7（13）：e008202[2023-08-10]. https://doi.org/10.1161/JAHA.117.008202.
[24] FUCHS F D，FUCHS S C. The effect of alcohol on blood pressure and hypertension[J/OL]. Curr Hypertens Rep，2021，23（10）：42[2023-08-10]. https://doi.org/10.1007/s11906-021-01160-7.
[25] RONKSLEY P E，BRIEN S E，TURNER B J，et al. Association of alcohol consumption with selected cardiovascular disease outcomes：a systematic review and meta-analysis[J/OL]. BMJ，2011，342：d671[2023-08-10]. https://doi.org/10.1136/bmj.d671.
[26] TAYLOR B，IRVING H M，BALIUNAS D，et al. Alcohol and hypertension：gender differences in dose-response relationships determined through systematic review and meta-analysis[J]. Addiction，2009，104（12）：1981-1990.
[27] LIU L，CHEN M X，ZHAO L L，et al. Ethanol induces platelet apoptosis[J]. Alcohol Clin Exp Res，2017，41（2）：291-298.
[28] SILCZUK A，HABRAT B. Alcohol-induced thrombocytopenia：current review[J/OL]. Alcohol，2020，86：9-16[2023-08-10]. https://doi.org/10.1016/j.alcohol.2020.02.166.
[29] SMITH S，FAIR K，GOODMAN A，et al. Consumption of alcohol leads to platelet inhibition in men[J]. Am J Surg，2019，217（5）：868-872.
[30] VINHOLT P J，HVAS A M，NIELSEN C，et al. Reduced platelet activation and platelet aggregation in patients with alcoholic liver cirrhosis[J]. Platelets，2018，29（5）：520-527.
[31] JOHNSEN S P，FROST L. Swimming upstream：disentangling the association between alcohol intake and venous thromboembolism[J]. Thromb Haemost，2019，119（6）：858-859.
[32] ZHANG X X，CHEN X R，YANG J，et al. Meta-analysis of alcohol consumption and venous thromboembolism[J]. J Public Health（Oxf），2022，44（3）：477-498.
[33] JOHANSSON M，JOHANSSON L，WENNBERG M，et al. Alcohol consumption and risk of first-time venous thromboembolism in men and women[J]. Thromb Haemost，2019，119（6）：962-970.
[34] WANG I J，BAE B K，CHO Y M，et al. Effect of acute alcohol intoxication on mortality，coagulation，and fibrinolysis in trauma patients[J/OL]. PloS One，2021，16（3）：e248810[2023-08-10]. https://doi.org/10.1371/journal.pone.0248810.
[35] TSITSOPOULOS P P，MARKLUND N，ROSTAMI E，et al. Association of the bleeding time test with aspects of traumatic brain injury in patients with alcohol use disorder[J]. Acta Neurochir（Wien），2020，162（7）：1597-1606.
[36] ALTURA B M，ALTURA B T，GEBREWOLD A. Alcohol-induced spasms of cerebral blood vessels：relation to cerebrovascular accidents and sudden death[J]. Science，1983，220（4594）：331-333.
[37] GUNDERSEN H，VAN WAGENINGEN H，GRÜNER R. Alcohol-induced changes in cerebral blood flow and cerebral blood volume in social drinkers[J]. Alcohol Alcohol，2013，48（2）：160-165.
[38] MARXEN M，GAN G，SCHWARZ D，et al. Acute effects of alcohol on brain perfusion monitored with arterial spin labeling magnetic resonance imaging in young adults[J]. J Cereb Blood Flow Metab，2014，34（3）：472-479.
[39] BUTCHER T J，CHUMIN E J，WEST J D，et al. Cerebral blood flow in the salience network of individuals with alcohol use disorder[J]. Alcohol Alcohol，2022，57（4）：445-451.
[40] DIENER H C，HANKEY G J. Primary and secondary prevention of ischemic stroke and cerebral hemorrhage：JACC focus seminar[J]. J Am Coll Cardiol，2020，75（15）：1804-1818.
[41] MYSIEWICZ S，NORTH K C，MOREIRA L，Jr，et al. Interspecies and regional variability of alcohol action on large cerebral arteries：regulation by KCNMB1 proteins[J/OL]. Am J Physiol Regul Integr Comp Physiol，2023，324（4）：R480-R496[2023-08-10]. https://doi.org/10.1152/ajpregu.00103.2022.
[42] NORTH K C，CHANG J，BUKIYA A N，et al. Extra-endothelial TRPV1 channels participate in alcohol and caffeine actions on cerebral artery diameter[J/OL]. Alcohol，2018，73：45-55[2023-08-10]. https://doi.org/10.1016/j.alcohol.2018.04.002.
[43] FERNÁNDEZ-SOLÀ J. The effects of ethanol on the heart：alcoholic cardiomyopathy[J/OL]. Nutrients，2020，12（2）：572[2023-08-10]. https://doi.org/10.3390/nu12020572.
[44] ROERECKE M，REHM J. Alcohol consumption，drinking patterns，and ischemic heart disease：a narrative review of meta-analyses and a systematic review and meta-analysis of the impact of heavy drinking occasions on risk for moderate drinkers[J/OL]. BMC Med，2014，12：182[2023-08-10]. https://doi.org/10.1186/s12916-014-0182-6.
[45] ROERECKE M，REHM J. Cause-specific mortality risk in alcohol use disorder treatment patients：a systematic review and meta-analysis[J]. Int J Epidemiol，2014，43（3）：906-919.
[46] WOOD A M，KAPTOGE S，BUTTERWORTH A S，et al. Risk thresholds for alcohol consumption：combined analysis of individual-participant data for 599 912 current drinkers in 83 prospective studies[J]. Lancet，2018，391（10129）：1513-1523.
[47] WHITMAN I R，AGARWAL V，NAH G，et al. Alcohol abuse and cardiac disease[J]. J Am Coll Cardiol，2017，69（1）：13-24.
[48] SCHEITZ J F，SPOSATO L A，SCHULZ-MENGER J，et al. Stroke-heart syndrome：recent advances and challenges[J/OL]. J Am Heart Assoc，2022，11（17）：e026528[2023-08-10]. https://doi.org/10.1161/JAHA.
122.026528.
[49] JEON S，CARR R. Alcohol effects on hepatic lipid metabolism[J]. J Lipid Res，2020，61（4）：470-479.
[50] HERNÁNDEZ-RUBIO A，SANVISENS A，BOLAO F，et al. Prevalence and associations of metabolic syndrome in patients with alcohol use disorder[J/OL]. Sci Rep，2022，12（1）：2625[2023-08-10]. https://doi.org/10.1038/s41598-022-06010-3.
[51] YANG X M，YAO L B，DAI L，et al. Alcohol predisposes obese mice to acute pancreatitis via adipose triglyceride lipase-dependent visceral adipocyte lipolysis[J]. Gut，2023，72（1）：212-214.
[52] YOU M，ARTEEL G E. Effect of ethanol on lipid metabolism[J]. J Hepatol，2019，70（2）：237-248.
[53] BADIA R R，PRADHAN R V，AYERS C R，et al. The relationship of alcohol consumption and HDL metabolism in the multiethnic Dallas heart study[J]. J Clin Lipidol，2023，17（1）：124-130.
[54] NOVA E，SAN MAURO-MARTÍN I，DÍAZ-PRIETO L E，et al. Wine and beer within a moderate alcohol intake is associated with higher levels of HDL-C and adiponectin[J/OL]. Nutr Res，2019，63：42-50[2023-08-10]. https://doi.org/10.1016/j.nutres.2018.12.007.
[55] CHO K H，NAM H S，KANG D J，et al. Long-term alcohol consumption caused a significant decrease in serum high-density lipoprotein（HDL）-cholesterol and apolipoprotein ai with the atherogenic changes of HDL in middle-aged Korean women[J/OL]. Int J Mol Sci，2022，23（15）：8623[2023-08-10]. https://doi.org/10.3390/ijms23158623.
[56] ANDRESEN-STREICHERT H，MÜLLER A，GLAHN A，et al. Alcohol biomarkers in clinical and forensic contexts[J]. Deutsch Arztebl Int，2018，115（18）：309-315.
[57] YANG W，KIM C K，KIM D Y，et al. Gamma-glutamyl transferase predicts future stroke：a Korean nationwide study[J]. Ann Neurol，2018，83（2）：375-386.
[58] LEE S M，HA E，RYOO J H. Serum gamma-glutamyltransferase levels predict the development of cerebral infarction in the Korean population[J/OL]. Neuropsychiatr Dis Treat，2021，17：2749-2756[2023-08-10]. https://doi.org/10.2147/NDT.S326450.
[59] LI S，WANG A，TIAN X，et al. Elevated gamma-glutamyl transferase levels are associated with stroke recurrence after acute ischemic stroke or transient ischemic attack[J]. CNS Neurosci Ther，2022，28（10）：1637-1647.
[60] LEE Y，SEO J H. Potential causal association between elevated gamma-glutamyl transferase level and stroke：a two-sample Mendelian randomization study[J/OL]. Biomolecules，2023，13（11）：1592[2023-08-10]. https://doi.org/10.3390/biom13111592.
[61] TAWIAH K D，RILEY S B，BUDELIER M M. Biomarkers and clinical laboratory detection of acute and chronic ethanol use[J]. Clin Chem，2022，68（5）：635-645.
[62] HELANDER A，WIELDERS J，ANTON R，et al. Standardisation and use of the alcohol biomarker carbohydrate-deficient transferrin（CDT）[J/OL]. Clin Chim Acta，2016，459：19-24[2023-08-10]. https://doi.org/10.1016/j.cca.2016.05.016.
[63] KUNUTSOR S K，KREMER D，EISENGA M F，et al. Self-reported alcohol consumption，carbohydrate deficient transferrin and risk of cardiovascular disease：the PREVEND prospective cohort study[J/OL]. Clin Chim Acta，2021，520：1-7[2023-08-10]. https://doi.org/10.1016/j.cca.2021.05.024.
[64] HARRIS J C，LEGGIO L，FAROKHNIA M. Blood biomarkers of alcohol use：a scoping review[J]. Curr Addict Rep，2021，8（4）：500-508.
[65] RÖHRICHT M，PASCHKE K，SACK P M，et al. Phosphatidylethanol reliably and objectively quantifies alcohol consumption in adolescents and young adults[J]. Alcohol Clin Exp Res，2020，44（11）：2177-2186.
[66] JOHANSSON K，JOHANSSON L，PENNLERT J，et al. Phosphatidylethanol levels，as a marker of alcohol consumption，are associated with risk of intracerebral hemorrhage[J]. Stroke，2020，51（7）：2148-2152.
[67] VATSALYA V，GALA K S，HASSAN A Z，et al. Characterization of early-stage alcoholic liver disease with hyperhomocysteinemia and gut dysfunction and associated immune response in alcohol use disorder patients[J/OL]. Biomedicines，2021，9（1）：7[2023-08-10]. https://doi.org/10.3390/biomedicines9010007.
[68] COPPOLA M，MONDOLA R. Correlation between plasma homocysteine levels and craving in alcohol dependent stabilized patients[J]. Clin Nutr，2018，37（3）：1061-1065.
[69] LARSSON S C，TRAYLOR M，MARKUS H S. Homocysteine and small vessel stroke：a mendelian randomization analysis[J]. Ann Neurol，2019，85（4）：495-501.
[70] PALMER B F，CLEGG D J. Electrolyte disturbances in patients with chronic alcohol-use disorder[J]. N Engl J Med，2017，377（14）：1368-1377.
[71] BAJ J，FLIEGER W，TERESIŃSKI G，et al. Magnesium，calcium，potassium，sodium，phosphorus，selenium，zinc，and chromium levels in alcohol use disorder：a review[J/OL]. J Clin Med，2020，9（6）：1901[2023-08-10]. https://doi.org/10.3390/jcm9061901.
[72] VANONI F O，MILANI G P，AGOSTONI C，et al. Magnesium metabolism in chronic alcohol-use disorder：meta-analysis and systematic review[J/OL]. Nutrients，2021，13（6）：1959[2023-08-10]. https://doi.org/10.3390/nu13061959.
[73] AIRAGNES G，VALTER R，DUCOUTUMANY G，et al. Magnesium in the treatment of alcohol withdrawal syndrome：a multicenter randomized controlled trial[J]. Alcohol Alcohol，2023，58（3）：329-335.
[74] CONNOR J. Alcohol consumption as a cause of cancer[J]. Addiction，2017，112（2）：222-228.
[75] HABER P S，RIORDAN B C，WINTER D T，et al. New Australian guidelines for the treatment of alcohol problems：an overview of recommendations[J/OL]. Med J Aust，2021，215：S3-S32[2023-08-10].
https://doi.org/10.5694/mja2.51254.
[76] 李艺，彭英. 《慢性酒精中毒性脑病诊治中国专家共识》解读[J]. 中国现代神经疾病杂志，2019，19（1）：1-4.
LI Y，PENG Y. Interpretation of “diagnoses and treatments of chronic alcoholic toxic cerebral encephalopathy：an expert consensus”[J]. Chinese Journal of Contemporary Neurology and Neurosurgery，2019，19（1）：1-4.
[77] BARNETT R. Alcohol use disorders[J/OL]. Lancet，2017，389（10064）：25[2023-08-10]. https://doi.org/10.1016/S0140-6736（16）32600-9.
[78] LANZ J，BINIAZ-HARRIS N，KUVALDINA M，et al. Disulfiram：mechanisms，applications，and challenges[J/OL]. Antibiotics（Basel），2023，12（3）：524[2023-08-10]. https://doi.
org/10.3390/antibiotics12030524.
[79] BURNETTE E M，NIETO S J，GRODIN E N，et al. Novel agents for the pharmacological treatment of alcohol use disorder[J]. Drugs，2022，82（3）：251-274.
[80] HO M F，ZHANG C，ZHANG L X，et al. TSPAN5 influences serotonin and kynurenine：pharmacogenomic mechanisms related to alcohol use disorder and acamprosate treatment response[J]. Mol Psychiatry，2021，26（7）：3122-3133.
[81] AVERY J. Naltrexone and alcohol use[J]. Am J Psychiatry，2022，179（12）：886-887.
[82] MIYATA H，TAKAHASHI M，MURAI Y，et al. Nalmefene in alcohol-dependent patients with a high drinking risk：randomized controlled trial[J]. Psychiatry Clin Neurosci，2019，73（11）：697-706.
[83] KRANZLER H R，SOYKA M. Diagnosis and pharmacotherapy of alcohol use disorder：a review[J]. JAMA，2018，320（8）：815-824.
[84] PATEL A K，BALASANOVA A A. Treatment of alcohol use disorder[J/OL]. JAMA，2021，325（6）：596[2023-08-10]. https://doi.org/10.1001/jama.2020.2012.
[85] LITT M D，KADDEN R M，TENNEN H. Treatment response and non‐response in CBT and network support for alcohol disorders：targeted mechanisms and common factors[J]. Addiction，2018，113（8）：1407-1417.
[86] BOß L，LEHR D，SCHAUB M P，et al. Efficacy of a web-based intervention with and without guidance for employees with risky drinking：results of a three-arm randomized controlled trial[J]. Addiction，2018，113（4）：635-646.
[87] SUNDSTRÖM C，GAJECKI M，JOHANSSON M，et al. Guided and unguided internet-based treatment for problematic alcohol use—a randomized controlled pilot trial[J/OL]. PloS One，2016，11（7）：e0157817[2023-08-10]. https://doi.org/10.1371/journal.pone.0157817.
[88] AUGSBURGER M，KAAL E，ÜLESOO T，et al. Effects of a minimal-guided on-line intervention for alcohol misuse in Estonia：a randomized controlled trial[J]. Addiction，2022，117（1）：108-117.
[89] GO V F，HUTTON H E，HA T V，et al. Effect of 2 integrated interventions on alcohol abstinence and viral suppression among Vietnamese adults with hazardous alcohol use and HIV：a randomized clinical trial[J/OL]. JAMA Netw Open，2020，3（9）：e2017115[2023-08-10]. https://doi.org/10.1001/jamanetworkopen.2020.17115.
[90] SLADE T，MEWTON L，O’DEAN S，et al. DSM-5 and ICD-11 alcohol use disorder criteria in young adult regular drinkers：lifetime prevalence and age of onset[J/OL]. Drug Alcohol Depend，2021，229：109184[2023-08-10]. https://doi.org/10.1016/j.drugalcdep.2021.109184.
[91] PAULUS D J，ROGERS A H，CAPRON D W，et al. Maximizing the use of the alcohol use disorders identification test（AUDIT）as a two-step screening tool[J/OL]. Addict Behav，2023，137：107521[2023-08-10]. https://doi.org/10.1016/j.addbeh.2022.107521.
[92] LÓPEZ-LAZCANO A I，LÓPEZ-PELAYO H，BALCELLS-OLIVERÓ M，et al. Validation of the alcohol smoking and substance involvement screening test（ASSIST）in acute psychiatric inpatients[J]. Adicciones，2022，34（4）：259-272.
[93] 李冰，沈渔邨，张伯全，等. 《酒精使用障碍筛查量表》（AUDIT）的测试[J/OL]. 中国心理卫生杂志，2003（1）：1-3[2023-08-10]. https://doi.org/10.3321/j.issn:1000-6729.2003.01.001.
LI B，SHEN Y C，ZHANG B Q，et al. The test of AUDIT in China[J/OL]. Chinese Mental Health Journal，2003（1）：1-3[2023-08-10]. https://doi.org/10.3321/j.issn:1000-6729.2003.01.001.